CryoStor References
Abstracts
2024 | CryoStor® References | Abstracts
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol
Authors: Middlebrooks, Al-Kharboosh, Chaichana, Zubair, E.H., R., K.L., A.C., Abarbanel, Twohy, Green, Trifiletti, D.N., E.L., J.J., D.M., Durand, Tzeng, Basil, Sherman, N., S.Y., A.N., W.J., Dickson, Ramos-Fresnedo, Almeida, Szymkiewicz, Quiñones-Hinojosa, D.W., A., J.P., E.C., A.
Published: Neurosurgery Practice, 2023;Dec;4:e00062
2023 | CryoStor® References | Abstracts
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon Platform
Authors: Purpura, Bryan, K., A., Middleton, K., Smith, T., Trainor, Leonard, N., D.
Published: Cytotherapy, 2023; 25:1349 - 1360
2022 | CryoStor® References | Abstracts
A Novel Cryopreservation and Biobanking Strategy to Study Lymphoid Tissue Stromal Cells in Lymphoproliferative Disorders
Authors: Allman, De Martin, and Maillard, Gonzalez, D., A., I., M., Fajgenbaum, Lϋetge, Stanossek, D.C., M., Y., Camiolo, Aster, Ferreira, E., J.C., A., Wertheim, Brandstadter, Ludewig, Gaudette, G., J.D., B., B.T.
2019 | CryoStor® References | Abstracts
ESGCT 27th Annual Congress In collaboration with SETGyc Barcelona, Spain October 22–25, 2019 Abstracts: Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: Jones, Ellison, Pereira, SA, SM, I., Bigger, Armenteros-Monterroso, Rivat, BW, E., C, Ogden, Booth, Diasakou, W., C., A., Wynn, Buckland, Thrasher, León-Rico, R., KF, AJ, D.
Published: Human Gene Therapy.Nov 2019.A1-A221
2019 | CryoStor® References | Abstracts
Manufacture of an ATMP for ex vivo gene therapy of mucopolysaccharidosis IIIA (MPSIIIA)
Authors: Jones, Ellison, Pereira, SA, SM, I., Bigger, Armenteros-Monterroso, Rivat, BW, E., C., Ogden, Booth, Diasakou, W., C., A., Wynn, Buckland, Thrasher, León-Rico, R., KF, AJ, D.
Published: Human Gene Therapy, 2019;30:11, A1-A221
2018 | CryoStor® References | Abstracts
A COMPARISON STUDY OF CURRENT FREEZING MEDIA VERSUS CRYOSTOR10 FOR CRYOPRESERVATION OF QC VIALS
Authors: Stasko, K., Paciulan, B., Clark, E.
Published: Cytotherapy
2018 | CryoStor® References | Abstracts
A Comprehensive Review of Umbilical Cord Cryopreservation: Umbilical Cord Tissue Banking Cryopreserved Technology and Standard Operating Procedure
Authors: Lee, Tsung (John) Dao
Published: Transfusion
2017 | CryoStor® References | Abstracts
Banking of Human Pluripotent Stem Cells
Authors: Biunno I, Ntai A
Published: Biopreservation and Biobanking
2017 | CryoStor® References | Abstracts
Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units.
Authors: Pineault N., Pasha R., Elmoazzen H.
Published: Transfusion
2016 | CryoStor® References | Abstracts
Biopreservation considerations in the evolving field of cellular therapies
Authors: Abazari A
Published: Cryobiology
2016 | CryoStor® References | Abstracts
Influencing Differentiation and Growth of Neural Progenitor Cells With Gene Silencing and Laminin
Authors: Hon Chooi W, Yian Chew S, Wyatt M, Ong W
Published: Univeristy of Pittsburgh, Swanson School of Engineering, Undergraduate Summer Research Abstracts
2016 | CryoStor® References | Abstracts
Transplantation of cryopreserved MSC rescues retinal ganglion cells following I/R injury
Authors: Burand A, Ankrum JA, et al., Gramlich OW, Zhu W
Published: ARVO Journal
2014 | CryoStor® References | Abstracts
C-25: Evaluation of closed system medical device for low volume storage for clinical studies involving regulatory T cells.
Authors: Thirkell S, Lowe K, Bushell A, Lombardi G., Fearnot ER, Fazekasova H
Published: Cryobiology
2013 | CryoStor® References | Abstracts
Analysis of HPC and HSC post-thaw viability, clonogenic capacity, and proliferative potential after cryopreservation in comercially available media
Authors: Leemhuis T, Almulhem N, Lutzko C
Published: Cytotherapy
2013 | CryoStor® References | Abstracts
Phenotypic properties of transmitted founder HIV-1
Authors: Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, et al., Parrish NF, Gao F
Published: The Proceedings of the National Academy of Sciences (PNAS)
2012 | CryoStor® References | Abstracts
Cell-based approaches for the treatment of systemic inflammation.
Authors: Lee K, Westover AJ, Smith PL, Buffington DA, Humes HD., Pino CJ, Yevzlin AS
Published: Nephrology Dialysis Transplantation
2009 | CryoStor® References | Abstracts
Notch-Induced Rat and Human Bone Marrow Stromal Cell Grafts Reduce Ischemic Cell Loss and Ameliorate Behavioral Deficits in Chronic Stroke Animals.
Authors: Hara K, Bankiewicz K, Maki M, Case C, Ali MM, Borlongan CV., Yu SJ, Bae E, Yu G, Yasuhara T, Xu L, Matsukawa N, McGrogan M
Published: Stem Cells and Development
September 2024 | CryoStor® References | Abstracts
Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collabo
Authors: Marks, Schäfer, Jin, D., R., P., Geng, Fontaine, Reems, H., M.J., J., Stroncek, Pati, Norris, D., S. for Biomedical Excellence for Safer Transfusion (BEST), P.J., Tanashi, Shaz, McKenna, M., B.H., D.H.
Published: Cytotherapy, 2024;26; Issue 6:531-539
September 2024 | CryoStor® References | Abstracts
Low molecular weight heparin decreases pro-coagulant activity in clinical MSC products
Authors: Triolo, Cox Jr, F., C.S., Gill, B.S., Cardenas, J.C., Schriner, Olson, J.B., S.D.
Published: Cytotherapy: Stromal Cell Therapy, 2024;26, Issue 2:194 - 200